Progress, Potential, and Possibilities Podcast / Show

Ira Pastor

Interviews and Discussions With Fascinating People Who are Creating A Better Tomorrow For All Of Us - Host - Ira S. Pastor

  1. 1d ago

    The Blood Test That Could Change Cancer Treatment Forever | Eric Matthews - General Manager, Biopharma, Natera

    Send us Fan Mail For decades, oncologists have had to wait until cancer became visible on a scan before knowing whether it had returned. But what if doctors could detect microscopic traces of cancer months earlier with a simple blood draw - and use that information to decide who actually needs treatment? Today we're exploring a breakthrough that may fundamentally change the way cancer is monitored and treated. Eric Matthews is General Manager of Biopharma at Natera ( https://www.natera.com/ ), a leader in personalized molecular diagnostics and the company behind Signatera, the first FDA-approved molecular residual disease companion diagnostic. Over the past 25 years, Eric has helped bring nine medicines to market across nineteen indication launches, building a career at the forefront of oncology, precision medicine, and biopharmaceutical innovation. Before joining Natera, Eric served as Chief Business Officer at Caris Life Sciences, where he focused on diagnostic, data, and drug discovery partnerships. Prior to that, he was Chief Commercial Officer at Arcus Biosciences, helping forge major strategic collaborations including Arcus' landmark partnership with Gilead Sciences. Eric's previous leadership roles include Vice President of Global Marketing for Immuno-Oncology at AstraZeneca and commercial leadership positions at Genentech and Roche, where he worked on some of the most influential cancer therapies of the modern era, including Avastin and Tecentriq. Eric holds an MBA in Health Sector Management, a Master's in Health Policy and Economics, and dual bachelor's degrees in Molecular Biology and Economics from Duke University. Today we discuss the future of molecular residual disease testing, how personalized blood-based diagnostics are changing cancer care, the recent FDA approval of Signatera as the first MRD companion diagnostic, and what the next decade may hold for truly individualized oncology. #CancerResearch #CancerDetection #PrecisionMedicine #Oncology #LiquidBiopsy #Signatera #Natera #CancerCare #Biotech #HealthcareInnovation #Immunotherapy #Tecentriq #BladderCancer #MolecularBiology #PersonalizedMedicine #CancerTreatment #MedicalInnovation #FutureOfMedicine #Biotechnology #ProgressPotentialPossibilities Support the show

    25 min
  2. 2d ago

    How Female Biology Shapes Skin Disease Across a Lifetime | Dr. Doral Fredericks, PharmD, MBA - Vice President and Head of Global Medical Affairs and Outcomes Research, Organon

    Send us Fan Mail For decades, medicine has recognized that pregnancy and menopause transform nearly every system in the body. Yet only recently have researchers begun asking a simple question: what happens to chronic skin diseases like eczema and psoriasis during these major biological transitions? The answers may reveal one of the biggest blind spots in modern medicine. Dr. Doral Fredericks, PharmD, MBA is Vice President and Head of Global Medical Affairs and Outcomes Research at Organon ( https://www.organon.com/ ), a global healthcare company focused on improving women's health throughout every stage of life. With nearly three decades of experience spanning clinical pharmacy, pharmaceutical development, medical affairs, and healthcare strategy, Dr. Fredericks has held senior leadership roles across some of the world's leading healthcare organizations, including Organon, Dermavant Sciences, ACADIA Pharmaceuticals, Bausch + Lomb, Novartis, AstraZeneca, and Kaiser Permanente. Throughout her career, Dr. Fredericks has led global medical affairs organizations, overseen clinical development programs, real-world evidence generation, physician education initiatives, and outcomes research efforts across multiple therapeutic areas. Her work has focused on translating scientific innovation into meaningful improvements in patient care while helping healthcare systems better understand the unique needs of diverse patient populations. Today, Dr. Fredericks is helping drive a growing conversation around female dermatology - a field examining how major biological transitions such as pregnancy, postpartum recovery, perimenopause, and menopause can profoundly influence chronic skin diseases including eczema, psoriasis, and other inflammatory conditions. On this episode, we'll explore why women's skin health remains an underrecognized area of medicine, how hormonal and immune changes across a woman's lifespan affect dermatologic disease, and what the future of personalized care may look like as researchers begin paying closer attention to the unique biology of female patients. #WomensHealth #Dermatology #Menopause #Psoriasis #Eczema #SkinHealth #Healthcare #PrecisionMedicine #AutoimmuneDisease #Hormones #Postpartum #PregnancyHealth #MedicalResearch #Inflammation #Medicine #Organon #Dermatologist #HealthyAging #Longevity #HealthcareInnovation #SciencePodcast #MedicalScience #FutureOfMedicine #SkinDisease #ProgressPotentialPossibilities Support the show

    28 min
  3. 3d ago

    55 Years Without a Diagnosis | Can AI Solve The Undiagnosed Condition Blind Spot? | Haresh Patel - Founder and CEO, Sanare Health AI

    Send us Fan Mail He spent fifty-five years searching for answers. Dozens of doctors. Hundreds of tests. Twelve different diagnoses. And what he discovered wasn't just a problem with medicine - it was a problem with the system itself. Haresh Patel ( https://hareshpatel.ai/ ) is an entrepreneur, engineer, Founder and CEO of Sanare Health AI ( https://sanarehealth.ai/ ), and author of the memoir The Ghost in My Body: What Twelve Doctors Couldn't Find ( https://www.amazon.com/Ghost-My-Body-Doctors-Couldnt-ebook/dp/B0GL561XNC ). After immigrating from India and earning an electrical engineering degree from the University of Notre Dame, Haresh built a distinguished career in Silicon Valley, ultimately founding Mercatus, a private-markets data platform that grew to manage more than $1.5 trillion in assets before being acquired by State Street in 2021. But behind that business success was a deeply personal story. For more than 55 years, Haresh lived with unexplained symptoms, navigating a maze of specialists, tests, and conflicting diagnoses without ever receiving a clear answer. Rather than accepting the limitations of the system, he applied the same systems-thinking and pattern-recognition skills that made him successful in technology and finance to his own health journey. That experience led Haresh to a provocative conclusion: many patients don't suffer from a lack of doctors - they suffer from a lack of synthesis. Modern medicine excels at specialization, but often struggles to connect information across disciplines, timelines, and life experiences. Today, Haresh is the founder of Sanare Health AI, an AI-powered diagnostic intelligence platform designed to help patients with complex, chronic, and undiagnosed conditions uncover patterns hidden within fragmented medical data. His mission is to give physicians a more complete picture of the patient, empower individuals to own their health stories, and help solve one of healthcare's most overlooked challenges: the millions of people still searching for answers. We discuss diagnostic failure, AI in medicine, data sovereignty, root-cause healthcare, and what happens when a patient spends a lifetime becoming the expert on his own condition. #HareshPatel #TheGhostInMyBody #SanareHealth #ArtificialIntelligence #AIHealthcare #RareDisease #UndiagnosedDisease #DiagnosticOdyssey #PrecisionMedicine #RootCauseMedicine #HealthcareInnovation #FutureOfMedicine #MedicalAI #HealthTech #ChronicIllness #PatientAdvocacy #Longevity #MedicalDiagnostics #ComplexPatients #ProgressPotentialPossibilities Support the show

    49 min
  4. 5d ago

    The Placenta: The Organ That Programs Human Health Before Birth | Dr. Perrie O'Tierney-Ginn, Ph.D. - Executive Director, Woman, Mother & Baby Research Institute, Tufts Medical Center

    Send us Fan Mail Before your heart, brain, or lungs fully developed, one remarkable temporary organ was making decisions that may influence your health for decades. Dr. Perrie O'Tierney-Ginn ( https://www.placentascience.com/ ) explains why the placenta could be the most important organ you've never thought about. Dr. Perrie O'Tierney-Ginn, Ph.D. is Executive Director of the Woman, Mother & Baby Research Institute at Tufts Medical Center ( https://www.tuftsmedicine.org/research-clinical-trials/research-institutes-research-specialty/woman-mother-baby-research-institute ) and a Research Associate Professor in both Obstetrics & Gynecology at Tufts University School of Medicine ( https://www.tuftsmedicine.org/research-clinical-trials/research-institutes-research-specialty/woman-mother-baby-research-institute/laboratories/otierney-ginn-laboratory ) and the Friedman School of Nutrition Science and Policy ( https://nutrition.tufts.edu/academics/faculty/perrie-otierney-ginn ). A self-described "Perinatal Ecologist," Dr. O'Tierney-Ginn studies one of the most remarkable - and often overlooked - organs in human biology: the placenta. Her research explores how a mother's nutritional status, metabolism, and environment shape placental function, influence fetal growth, and ultimately affect lifelong health outcomes. Supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Dr. O'Tierney-Ginn's work focuses on understanding how nutrients are transported from mother to baby, how maternal obesity and metabolic health alter fetal development, and how the placenta acts as a sophisticated biological sensor that helps determine the earliest foundations of human health. With a Ph.D. in Cell Biology and Anatomy from Queen's University and leadership roles at Case Western Reserve University and Tufts Medical Center, Dr. O'Tierney-Ginn is helping redefine our understanding of pregnancy - not as a nine-month event, but as one of the most important developmental windows influencing health across the entire lifespan. #Placenta #Pregnancy #MaternalHealth #WomensHealth #DevelopmentalBiology #Longevity #Metabolism #Obesity #Diabetes #Nutrition #PrecisionMedicine #Epigenetics #Microbiome #SciencePodcast #Medicine #FetalDevelopment #TuftsMedicine #PublicHealth #PreventiveMedicine #FutureOfHealth Support the show

    1h 24m
  5. Jun 19

    Canine Superpowers: The Future of Early Cancer Detection | Itamar Bitan - Co-Founder, Dognosis

    Send us Fan Mail Dogs can detect explosives, narcotics, missing persons, and even disease. But what if their greatest superpower isn't finding things - it's sensing molecular changes inside the human body long before symptoms appear? Today we're exploring whether the canine nose may hold the key to the next generation of cancer diagnostics. Itamar Bitan is the Co-Founder of Dognosis  ( https://www.dognosis.tech/ ), a pioneering company working to unlock one of nature's most extraordinary sensing systems - the canine nose - and combine it with cutting-edge brain-computer interfaces and machine learning. Driven by a passion for both human health and working dogs, Itamar brings together an unusual blend of expertise spanning elite military operations, canine behavior, disease detection, and technology innovation. He spent nearly four years serving in Oketz, the Israeli Defense Forces' elite special operations K9 unit, where he worked as both a combat soldier and commander, developing deep expertise in canine training, scent detection, and high-pressure operational environments. Following his military service, Itamar became the first employee and Head of Operations at Dog-Prognose, a groundbreaking Israeli startup focused on disease-detection dogs, helping advance the use of canine scent detection for medical applications. Today, at Dognosis, Itamar and his team are pursuing an ambitious vision: digitizing canine scent perception itself. By combining the remarkable olfactory abilities of trained dogs with brain-computer interfaces, artificial intelligence, and machine learning, Dognosis aims to create a new generation of diagnostic tools capable of detecting diseases - including cancer - earlier, faster, and potentially more accurately than ever before. Itamar's work raises profound questions about the future of medicine, the untapped biological capabilities of animals, and how technology may help us translate nature's most sophisticated sensing systems into scalable healthcare solutions. #CancerDetection #ArtificialIntelligence #AI #BrainComputerInterface #BCI #CancerResearch #EarlyDetection #Dogs #MedicalInnovation #Biotechnology #FutureOfMedicine #HealthcareInnovation #MachineLearning #PrecisionMedicine #LiquidBiopsy #CanineDetection #CancerScreening #HealthTech #Diagnostics #SciencePodcast #STEM #Innovation #FutureTech #ProgressPotentialPossibilities Support the show

    42 min
  6. Jun 19

    The Intelligent Age Explained: Professor Klaus Schwab on AI, Longevity & the Future of Work

    Send us Fan Mail For decades, we’ve talked about the digital revolution - but according to Professor Klaus Schwab, we’ve already moved beyond it. We’re now entering what he calls the Intelligent Age - where intelligence itself becomes the most valuable resource on Earth. Professor Klaus Schwab is Founder of the World Economic Forum and one of the most influential thinkers on how technological and societal systems evolve ( https://schwabacademy.org/klaus-schwab ). Over more than five decades, Professor Schwab helped shape global conversations around stakeholder capitalism and the Fourth Industrial Revolution - frameworks that examined how digital technologies were transforming economies and institutions. Now, in a new phase of his work, Professor Schwab has turned his focus to what he calls the “Intelligent Age” - a period defined not just by digital tools, but by the convergence of artificial intelligence, biotechnology, and quantum computing as foundational drivers of society. Through a series of recent books - including Thriving and Leading in the Intelligent Age, Longevity and Retirement in the Intelligent Age, Restoring Truth and Trust, and Universities in the Intelligent Age - he explores how intelligence itself is becoming the world’s most important resource, and what that means for leadership, education, institutions, and human purpose. At the core of Professor Schwab's work is a central question: How do we ensure that as machines become more intelligent, societies become more human? Important Episode Links - Schwab Academy - https://schwabacademy.org/ Schwab Foundation for Social Entrepreneurship - https://www.schwabfound.org/home Global Shapers Community - https://www.globalshapers.org/home Thriving and Leading in the Intelligent Age: Mastering Change with Purpose - https://www.amazon.com/Thriving-Leading-Intelligent-Age-Mastering/dp/297019547X/ref=tmm_hrd_swatch_0 Longevity and Retirement in the Intelligent Age: Opening New Horizons in Later Life - https://www.amazon.com/Longevity-Retirement-Intelligent-Age-Horizons/dp/2970198800/ref=tmm_pap_swatch_0 Universities, Professors, and Students in the Intelligent Age: A Call for Systems Change - https://www.amazon.com/Universities-Professors-Students-Intelligent-Age/dp/2970198878/ref=tmm_hrd_swatch_0 Restoring Truth and Trust: An Agenda for the Intelligent Age - https://www.amazon.com/Restoring-Truth-Trust-Agenda-Intelligent/dp/2970198835/ref=tmm_pap_swatch_0  #KlausSchwab #IntelligentAge #ArtificialIntelligence #FutureOfWork #LifelongLearning #FourthIndustrialRevolution #AI #Longevity #FutureOfEducation #DigitalTransformation #HumanCentricAI #Leadership #Innovation #GlobalEconomy #SystemsThinking #FutureOfSociety #EducationReform #AIRevolution #TechnologyTrends #WorkforceTransformation #PurposeDrivenLeadership #Reskilling #Upskilling #FutureTrends #Podcast Support the show

    47 min
  7. Jun 19

    The Science of Human Potential: How the Brain Shapes Aging, Health & Performance | Dr. Srini Pillay

    Send us Fan Mail What if aging isn’t just biology…but also psychology - and your brain is quietly shaping how fast you age every day? Dr. Srini Pillay, MD ( https://drsrinipillay.com/ ) is a Harvard-trained psychiatrist, brain researcher, entrepreneur, author, and expert in the science of human potential, resilience, and longevity. Dr. Pillay previously served as Assistant Professor of Psychiatry at Harvard Medical School and directed both the Outpatient Anxiety Disorders Program and the Panic Disorders Research Program in Brain Imaging at McLean Hospital, one of the world’s leading psychiatric institutions. Over the course of his career, Dr. Pillay has focused on understanding how the brain shapes performance, creativity, emotional health, leadership, and even biological aging. His work bridges neuroscience, psychiatry, technology, and human behavior - translating cutting-edge brain science into practical tools for individuals, organizations, and healthcare systems. Dr. Pillay is the co-founder and Chief Medical Officer of Reulay ( https://www.reulay.com/ ), an AI-driven digital therapeutics and mindset technology company focused on healthy longevity, stress reduction, and human performance. He is also founder of the NeuroBusiness Group ( https://nbgcorporate.com/ ), where he works with leaders and organizations around the world on brain-based approaches to innovation, adaptability, resilience, and navigating complexity in the age of AI. Dr. Pillay is the author of several influential books including Tinker Dabble Doodle Try ( https://www.amazon.com/Tinker-Dabble-Doodle-Try-Unfocused/dp/1101883650 ), which explores the neuroscience of creativity and the untapped power of the brain’s unconscious processing systems. Today, we’ll explore the fascinating intersection of neuroscience, psychobiology, longevity, mindset, AI-powered therapeutics, creativity, and the future of human performance - and ask how our thoughts, attention, and environments may be shaping our biology far more than we realize. Important Episode Links -  Reulay: https://www.reulay.com/mindset?via=dr-srini Implementing The Science Behind the Law of Attraction: https://loacourse.drsrinipillay.com/special Dr. Srini Pillay Socials: IG: https://www.instagram.com/drsrinipillay/ LinkedIn: https://www.linkedin.com/in/drsrinipillay/ Meta: https://www.facebook.com/SriniPillayMD X: https://x.com/drsrinipillay TikTOK: https://www.tiktok.com/@dr.srinipillay Substack: https://drsrinipillay.substack.com/?utm_campaign=profile_chips Dr. Srini Pillay Free products: Ideal Self Guide: https://nas.com/drsrini/products/ideal-self-guide Weekly newsletter on mind-body connection: Sign up here: https://drsrinipillay.com/ Dr. Srini Pillay Paid products: Book: Tinker Dabble Doodle Try: https://www.amazon.com/Tinker-Dabble-Doodle-Try-Unfocused/dp/1101883650 Book: Life Unlocked: https://www.amazon.com/Life-Unlocked-Revolutionary-Lessons-Overcome/dp/1609611462 #Neuroscience #Longevity #HumanPotential #MindsetMatters #Psychobiology #BrainHealth #AgingScience #Healthspan #MentalHealth #StressManagement #AIHealth #DigitalTherapeutics #Neuroplasticity #FutureOfHealth #HealthTech #WellbeingScience #PerformanceScience #MindBodyConnection #LongevityScience Support the show

    58 min
  8. Jun 16

    Behind the Camera: The Untold Story of a Sports Producer's Health Battle

    Send us Fan Mail He spent decades interviewing some of the toughest athletes on the planet. Meanwhile, he was quietly battling a condition that at times covered nearly his entire body. Today, for the first time, Paul shares the story behind the story. Paul is an 11-time Emmy Award-winning sports television producer whose career has taken him behind the scenes of some of the biggest moments in sports and entertainment. For more than sixteen years, Paul served as a senior producer, helping create acclaimed documentaries, television series, and feature programming seen by millions. Along the way he has interviewed and produced stories featuring some of the most recognizable names in sports and popular culture, including Tom Brady, Peyton Manning, Michael Jordan, Steph Curry, Charles Barkley, Deion Sanders, Eminem, and many others. Paul has led large-scale productions, won multiple national Emmy Awards, and directed feature-length documentaries, including projects that reached the top of the streaming charts. But behind that successful career was a challenge most viewers never knew about. Since childhood, Paul has lived with severe eczema, a chronic inflammatory skin condition that at times affected nearly his entire body. The condition impacted everything from sleep and travel to confidence, comfort, and everyday interactions. For years he largely kept those struggles private while continuing to work in some of the most visible and demanding environments in professional sports media. Today we'll talk about Paul's remarkable career in sports storytelling, what it was like navigating a visible chronic condition in a culture that often celebrates toughness and silence, and why broader conversations around men's health need to include conditions that affect quality of life, mental well-being, and self-confidence. Important Episode Links -  Nemluvio Web Page - https://www.nemluvio.com/ Nemluvio Safety Information - https://www.galderma.com/sites/default/files/2024-12/Nemluvio_Dual%20PI%20for%20website%2013Dec24.pdf Nemluvio FDA Approval Press - https://www.galderma.com/news/galderma-receives-us-fda-approval-nemluvior-nemolizumab-patients-moderate-severe-atopic #MensHealth #EczemaAwareness #ChronicIllness #InvisibleIllness #AtopicDermatitis #MentalHealth #HealthAndWellness #SportsMedia #NFLFilms #Resilience #QualityOfLife #HiddenStruggles #Nemluvio #MensHealthMonth #HealthAwareness #PersonalStory #PodcastInterview #ProgressPotentialPossibilities #PPPShow #ChronicDisease #Inspiration Support the show

    29 min

About

Interviews and Discussions With Fascinating People Who are Creating A Better Tomorrow For All Of Us - Host - Ira S. Pastor

You Might Also Like